Open Access
Med Buccale Chir Buccale
Volume 21, Number 3, juillet 2015
Page(s) 199 - 201
Section Cas clinique / Short case report
Published online 30 July 2015
  1. Malan J, Ettinger K, Naumann E, Beirne OR. The rela- tionship of denosumab pharmacology and osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114(6):671-6. [CrossRef] [PubMed] [Google Scholar]
  2. Van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, Van Rijswijk CS, et al. The clinical approach toward giant cell tumor of bone. Oncologist 2014;19(5):550-61. [CrossRef] [PubMed] [Google Scholar]
  3. Pichardo SEC, Kuypers SCC, Van Merkesteyn JPR. Denosumab osteonecrosis of the mandible: a new entity? A case report. J Craniomaxillofac Surg 2013;41(4):e65-9. [CrossRef] [PubMed] [Google Scholar]
  4. Fizazi K, Carducci M, Smith M, Damiao R, Brown J, Karsch L, et al. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised double-blind study. Lancet 2011;377(9768):813-22. [CrossRef] [PubMed] [Google Scholar]
  5. Lipton A, Fizazi K, Stopeck ATHenry DH, Brown JE, Yardley DA, et al. Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised phase 3 trials. Eur J Cancer 2012;48(16):3082-92. [CrossRef] [PubMed] [Google Scholar]
  6. Sutton RA, Mumm S, Coburn SPEricson KL, Whyte MP. “Atypical femoral fractures” during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 2012;27(5):987-94. [CrossRef] [PubMed] [Google Scholar]
  7. Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, et al. Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw? Oncologist 2012;17(8):1114-9. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.